Early BCG-Denmark and Neonatal Mortality Among Infants Weighing <2500 g: A Randomized Controlled Trial

BACKGROUND: BCG vaccine may reduce overall mortality by increasing resistance to nontuberculosis infections. In 2 randomized trials in Guinea-Bissau of early BCG-Denmark (Statens Serum Institut) given to low-weight (LW) neonates (<2500 g at inclusion) to reduce infant mortality rates, we observed...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Infect Dis
Autors principals: Biering-Sørensen, Sofie, Aaby, Peter, Lund, Najaaraq, Monteiro, Ivan, Jensen, Kristoffer Jarlov, Eriksen, Helle Brander, Schaltz-Buchholzer, Frederik, Jørgensen, Anne Sofie Pinstrup, Rodrigues, Amabelia, Fisker, Ane Bærent, Benn, Christine Stabell
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2017
Matèries:
Articles and Commentaries
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5849087/
https://ncbi.nlm.nih.gov/pubmed/29579158
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/cix525
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars